Elevated expression of DKK1 is associated with cytoplasmic/nuclear β-catenin accumulation and poor prognosis in hepatocellular carcinomas

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 948-957

  Yu, Bin ^a,b   Yang, Xinrong ^c   Xu, Yang ^c   Yao, Genfu ^b   Shu, Huiqun ^b   Lin, Biaoyang ^d   Hood, Leroy ^e   Wang, Hongyang ^b   Yang, Shengli ^b   Gu, Jianren ^b   Fan, Jia ^c   Qin, Wenxin ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Catenin; DKK1; HCC; Predictor; Tumor tissue microarray

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; DICKKOPF 1 PROTEIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL INVASION; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOPLASM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 64749106861     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.11.020     Document Type: Article

References (32)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Tang Z.Y., Ye S.L., Liu Y.K., Qin L.X., Sun H.C., Ye Q.H., et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004) 187-196
3. Yang Y., Nagano H., Ota H., Morimoto O., Nakamura M., Wada H., et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 141 (2007) 196-202
4. Mann C.D., Neal C.P., Garcea G., Manson M.M., Dennison A.R., and Berry D.P. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43 (2007) 979-992
5. Llovet J.M., and Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 (2008) S20-S37
6. Qin L.X., and Tang Z.Y. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol 130 (2004) 497-513
7. Llovet J.M., Di Bisceglie A.M., Bruix J., Kramer B.S., Lencioni R., Zhu A.X., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 698-711
8. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., and Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391 (1998) 357-362
9. Fedi P., Bafico A., Nieto Soria A., Burgess W.H., Miki T., Bottaro D.P., et al. Isolation and biochemical characterization of the human DKKK1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 274 (1999) 19465-19472
10. González-Sancho J.M., Aguilera O., Garci{dotless}́a J.M., Pendás-Franco N., Peña C., Cal S., et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24 (2005) 1098-1103
11. Wirths O., Waha A., Weggen S., Schirmacher P., Kühne T., Goodyer C.G., et al. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest 83 (2003) 429-434
12. Forget M.A., Turcotte S., Beauseigle D., Godin-Ethier J., Pelletier S., Martin J., et al. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96 (2007) 646-653
13. Patil M.A., Chua M.S., Pan K.H., Lin R., Lih C.J., Cheung S.T., et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 24 (2005) 3737-3747
14. Yamashita T., Forgues M., Wang W., Kim J.W., Ye Q., Jia H., et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68 (2008) 1451-1461
15. Xie L., Qin W., Li J., He X., Zhang H., Yao G., et al. BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells. Oncol Rep 17 (2007) 605-610
16. Poon R.T., Ng I.O., Lau C., Yu W.C., Yang Z.F., Fan S.T., et al. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20 (2002) 1775-1785
17. Wittekind C. Pitfalls in the classification of liver tumors. Pathology 27 (2006) 289-293
18. Gao Q., Qiu S.J., Fan J., Zhou J., Wang X.Y., Xiao Y.S., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25 (2007) 2586-2593
19. Yamabuki T., Takano A., Hayama S., Ishikawa N., Kato T., Miyamoto M., et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67 (2007) 2517-2525
20. Terris B., Pineau P., Bregeaud L., Valla D., Belghiti J., Tiollais P., et al. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18 (1999) 6583-6588
21. Shimada M., Hamatsu T., Yamashita Y., Rikimaru T., Taguchi K., Utsunomiya T., et al. Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis. World J Surg 25 (2001) 991-995
22. Niida A., Hiroko T., Kasai M., Furukawa Y., Nakamura Y., Suzuki Y., et al. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23 (2004) 8520-8526
23. Peng S.Y., Chen W.J., Lai P.L., Jeng Y.M., Sheu J.C., and Hsu H.C. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 112 (2004) 44-50
24. Hsu Y.C., Fu H.H., Jeng Y.M., Lee P.H., and Yang S.D. Proline directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma. J Clin Oncol 24 (2006) 3780-3788
25. Zhu X.D., Zhang J.B., Zhuang P.Y., Zhu H.G., Zhang W., Xiong Y.Q., et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26 (2008) 2707-2716
26. Ramesh S., Nash J., and McCulloch P.G. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 81 (1999) 1392-1397
27. Hugh T.J., Dillon S.A., Taylor B.A., Pignatelli M., Poston G.J., and Kinsella A.R. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 80 (1999) 1046-1051
28. Inagawa S., Itabashi M., Adachi S., Kawamoto T., Hori M., Shimazaki J., et al. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 8 (2002) 450-456
29. Schmitt-Gräff A., Ertelt V., Allgaier H.P., Koelble K., Olschewski M., Nitschke R., et al. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 38 (2003) 470-480
30. Tulac S., Overgaard M.T., Hamilton A.E., Jumbe N.L., Suchanek E., and Giudice L.C. Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab 91 (2006) 1453-1461
31. Aguilera O., Peña C., Garci{dotless}́a J.M., Larriba M.J., Ordóñez-Morán P., Navarro D., et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28 (2007) 1877-1884
32. Kane N., Jones M., Brosens J.J., Saunders P.T., Kelly R.W., and Critchley H.O. Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells. Mol Endocrinol 22 (2008) 716-728